168 related articles for article (PubMed ID: 3279988)
1. Malignant hyperthermia. Dantrolene--dynamics and kinetics.
Harrison GG
Br J Anaesth; 1988 Feb; 60(3):279-86. PubMed ID: 3279988
[No Abstract] [Full Text] [Related]
2. Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia.
López JR; López M; Allen P
Acta Cient Venez; 1990; 41(2):135-7. PubMed ID: 2135562
[No Abstract] [Full Text] [Related]
3. Effect of dantrolene on leg metabolism in porcine malignant hyperthermia.
Hall GM; Lucke JN; Orchard C; Lovell R; Lister D
Anaesthesia; 1982 Dec; 37(12):1167-70. PubMed ID: 7181063
[TBL] [Abstract][Full Text] [Related]
4. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
López JR; Medina P; Alamo L
Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
[TBL] [Abstract][Full Text] [Related]
5. Drug treatment of malignant hyperpyrexia.
Austin KL; Denborough MA
Anaesth Intensive Care; 1977 Aug; 5(3):207-13. PubMed ID: 900461
[TBL] [Abstract][Full Text] [Related]
6. Secretion of dantrolene into breast milk after acute therapy of a suspected malignant hyperthermia crisis during cesarean section.
Fricker RM; Hoerauf KH; Drewe J; Kress HG
Anesthesiology; 1998 Oct; 89(4):1023-5. PubMed ID: 9778021
[No Abstract] [Full Text] [Related]
7. [Dantrolene. Pharmacological and therapeutic aspects].
Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
[TBL] [Abstract][Full Text] [Related]
8. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
[TBL] [Abstract][Full Text] [Related]
9. [Sodium dantrolene].
Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM; Sanz Mazó M
Rev Esp Anestesiol Reanim; 1985; 32(4):179-83. PubMed ID: 3901158
[No Abstract] [Full Text] [Related]
10. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Ward A; Chaffman MO; Sorkin EM
Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
[TBL] [Abstract][Full Text] [Related]
11. Dantrolene and "ecstasy".
Denborough MA; Hopkinson KC
Med J Aust; 1997 Feb; 166(3):165-6. PubMed ID: 9059444
[No Abstract] [Full Text] [Related]
12. Verapamil and malignant hyperthermia--case reports.
Keilani MR; Al-Shanableh JS
Middle East J Anaesthesiol; 1985 Feb; 8(1):37-45. PubMed ID: 4010529
[No Abstract] [Full Text] [Related]
13. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
Nelson TE; Flewellen EH
Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
[TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia: clinical course and metabolic changes in two patients.
Rutberg H; Håkanson E
Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577
[TBL] [Abstract][Full Text] [Related]
15. Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia.
Lopez JR; Gerardi A; Lopez MJ; Allen PD
Anesthesiology; 1992 May; 76(5):711-9. PubMed ID: 1575338
[TBL] [Abstract][Full Text] [Related]
16. [Malignant hyperthermia].
Grote B
Anaesthesist; 1980 Feb; 29(2):53-4. PubMed ID: 7377524
[No Abstract] [Full Text] [Related]
17. Treatment of malignant hyperthermia with dantrolene.
Cooper JM; Jones HR; Williamson JW
J Miss State Med Assoc; 1983 Oct; 24(10):259-61. PubMed ID: 6644804
[No Abstract] [Full Text] [Related]
18. Dantrolene dose response in awake man: implications for management of malignant hyperthermia.
Flewellen EH; Nelson TE; Jones WP; Arens JF; Wagner DL
Anesthesiology; 1983 Oct; 59(4):275-80. PubMed ID: 6614536
[No Abstract] [Full Text] [Related]
19. Dantrolene.
Hetherington N
Aust Nurses J; 1992 Mar; 21(8):28-9. PubMed ID: 1605782
[No Abstract] [Full Text] [Related]
20. Dantrolene.
Britt BA
Can Anaesth Soc J; 1984 Jan; 31(1):61-75. PubMed ID: 6362802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
